ESMO Press Releases

If you require further information regarding any of the press releases listed below, please do not hesitate to contact us (select 'Press & Media').

Filter

Date Title Topic
22 Oct 2018 Immunotherapy may become new first line treatment in some metastatic colorectal cancers [ESMO 2018 Press Release] Gastrointestinal cancers
21 Oct 2018 Local radiotherapy improves survival in metastatic prostate cancer with low disease burden [ESMO 2018 Press Release] Genitourinary cancers
21 Oct 2018 Olaparib maintenance extends progression-free survival by estimated 3 years in advanced ovarian cancer [ESMO 2018 Press Release] Gynaecologic malignancies
21 Oct 2018 Avelumab plus axitinib significantly improve progression-free survival in untreated renal cell carcinoma [ESMO 2018 Press Release] Genitourinary cancers
21 Oct 2018 Erlotinib improves progression-free survival in early mutated non-small cell lung cancer [ESMO 2018 Press Release] Lung and other thoracic tumours
21 Oct 2018 Multi-strain probiotic reduces chemotherapy-induced diarrhoea [ESMO 2018 Press Release] Palliative and supportive care
21 Oct 2018 Drugs for treating breast cancer in women are effective and well tolerated in men [ESMO 2018 Press Release] Breast cancer - Cancer in Special Situations / Population
21 Oct 2018 Barriers to early clinical trial access for adolescents and young adults still exist, study shows [ESMO 2018 Press Release] Cancer in Special Situations / Population - Personalised medicine
20 Oct 2018 Targeting specific genomic mutation in breast cancer improves outcomes, first study shows [ESMO 2018 Press Release] Breast cancer
20 Oct 2018 Epigenetic therapy worth pursuing in hormone receptor positive advanced breast cancer [ESMO 2018 Press Release] Breast cancer
20 Oct 2018 New option for women with advanced breast cancer resistant to hormone therapy [ESMO 2018 Press Release] Breast cancer
20 Oct 2018 Some patients with metastatic triple negative breast cancer live longer with immunotherapy [ESMO 2018 Press Release] Breast cancer
20 Oct 2018 Zoledronic acid improves disease-free survival in premenopausal HR+ early breast cancer [ESMO 2018 Press Release] Breast cancer
20 Oct 2018 Oncologists demand more education on the use of biosimilars: ESMO takes action [ESMO 2018 Press Release] Anticancer agents & Biologic therapy
20 Oct 2018 Immunotherapy is safe and feasible in cancer patients treated for HIV, study suggests [ESMO 2018 Press Release]